FDA: Chantix may carry heart risks
December 13, 2012 (WLS) -- The Federal Drug Administration is warning that the stop-smoking drug Chantix may carry heart risks.
The FDA says as a result, doctors should weigh the risks of the drug against its benefits.
A major review of the drug found slightly higher rates of serious cardiovascular events, including non-fatal heart attacks, non-fatal stroke and cardiovascular-related death.
Experts are quick to point out that the increased risk was not statistically significant. They are asking that smokers talk to their doctors before taking the drug.
- Snow, cold fail to deter holiday shoppers
- Chicago pastor under investigation for child sex abuse
- ABC 7 Special: Monday Night Monsters
- ABC7 Weather Forecast
- 1 dead, several injured in Racine pile-up
- Patients celebrate holidays at Ronald McDonald House
- 2-year-old girl killed by dog on South Side
- Driver charged after bicyclist killed in Douglas Park accident
- FEMA canvassing tornado areas in Central Ill.
- Blackhawks G Crawford leaves game early with injury
- Chicago marks passing of Nelson Mandela
- Bears, Cowboys prepped for frigid Monday game
- Cold weather brings flight delays, cancellations
- abcnews: Man trapped in empty plane at Houston Airport
Most Viewed StoriesMost Viewed Photos